Efficacy and safety of immune checkpoint inhibitors combined anti-angiogenic therapy in patients with unresectable hepatocellular carcinoma: A meta-analysis
a School of Medicine, University of Electronic Science and Technology of China, Chengdu, China;b Department of Oncology, Nanchong Central Hospital, Nanchong, China;c Department of Pathology, Nanchong Central Hospital, Nanchong, China.